Logo

Getting In On the Google Money

Oct 02, 2009

Google Ventures, formed back in March, has made its first investment into a biotech company, according to Fierce Biotech. The company invested about $13 million into antibody start-up Adimabm, which uses computational approaches to develop its antibody library. Google Venture plans to invest $100 million in biotech in the coming year. "Google Ventures has a pretty broad mandate," managing partner William Maris says to Dow Jones. "We're looking for [companies] that have potential to make a big impact."

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.